New frontiers of immunotherapy for HIV.
作者信息
Haynes B F
机构信息
Duke Center for AIDS Research, Duke University Medical Center, Durham, North Carolina 27710, USA.
出版信息
Lancet. 1996 Dec 7;348(9041):1531-2. doi: 10.1016/S0140-6736(05)66165-X.
PMID:8950876
Abstract
摘要
相似文献
1
New frontiers of immunotherapy for HIV.HIV免疫疗法的新前沿
Lancet. 1996 Dec 7;348(9041):1531-2. doi: 10.1016/S0140-6736(05)66165-X.
2
AIDS and immune dysfunction. Alternative etiologic mechanisms.
Contrib Microbiol Immunol. 1989;11:289-304.
3
DNA vaccines expressing soluble CD4-envelope proteins fused to C3d elicit cross-reactive neutralizing antibodies to HIV-1.表达与C3d融合的可溶性CD4包膜蛋白的DNA疫苗可引发针对HIV-1的交叉反应性中和抗体。
Virology. 2004 Oct 25;328(2):292-300. doi: 10.1016/j.virol.2004.07.031.
4
Update on HIV vaccines: which way now?HIV疫苗的最新情况：现在何去何从？
Curr Med Chem. 2011;18(26):3952. doi: 10.2174/092986711796957275.
5
First AIDS vaccine trial launched.首次艾滋病疫苗试验启动。
Science. 1998 Jun 12;280(5370):1697.
6
Immunopathogenesis and immunotherapy in AIDS virus infections.艾滋病病毒感染中的免疫发病机制与免疫治疗
Nat Med. 2003 Jul;9(7):861-6. doi: 10.1038/nm0703-861.
7
Molecular biological bases of resistance to HIV/AIDS (the hypothesis with elements of the theory).
Mikrobiol Z. 1995 Jul-Aug;57(4):89-105.
8
Public health. A sound rationale needed for phase III HIV-1 vaccine trials.公共卫生。HIV-1疫苗三期试验需要合理依据。
Science. 2004 Jan 16;303(5656):316. doi: 10.1126/science.1094620.
9
[More and more of HIV non-B infections in Germany, too].[德国的HIV非B亚型感染也越来越多]
Dtsch Med Wochenschr. 1997 Oct 2;122(40):A9.
10
Carbohydrate targets in HIV vaccine research: lessons from failures.HIV 疫苗研究中的碳水化合物目标：失败教训。
Immunotherapy. 2009 Sep;1(5):777-94. doi: 10.2217/imt.09.44.
引用本文的文献
1
Multiple low-dose challenges in a rhesus macaque AIDS vaccine trial result in an evolving host response that affects protective outcome.在一项恒河猴艾滋病疫苗试验中，多次低剂量激发导致宿主反应不断演变，进而影响保护效果。
Clin Vaccine Immunol. 2014 Dec;21(12):1650-60. doi: 10.1128/CVI.00455-14. Epub 2014 Oct 1.
Zotero 插件